Reliability and validity for Turkish version of Lei̇cester Cough Questionnaire in copd patients
2016
0 views
0 downloads
Advisor: Yrd. Doç. Dr. Tuğba Göktalay
Abstract (EN)
There is no questionnaire to assess the impact and severity of chronic cough in patients with COPD in Turkey. For this reason, we want to validate the Turkish version of Leicester Cough Questionnaire (LCQ) in COPD patients with chronic cough. 71 male, 4 female, total 75 COPD patients (GOLD B,C,D,) with chronic cough who had been followed at Celal Bayar University Medical Faculty Chest Disease Department and 75 control group were included into the study. Mean age of patients was 62,32 ± 7,8 years. For internal consistency, cronbach alpha coefficients of all subscales ranged between 0,72-0,86 and calculated as 0,89 for total index. In test-retest reliabilty, the correlation coefficient ranged between 0,609-0,783 for each question and calculated as r=0,885 for total LCQ score. For validity analysis, relationship between LCQ scores and SF-36 and WHOQOL-BREF-TR scores were searched and a strong statistical correlation was found (p<0,05). As a result, Turkish version of LCQ has been found to have accepable reliability and validty for COPD patients with chronic cough
Author
Dr. Fikret Kurhan
How to Cite
Fikret Kurhan (Medical Specialty Thesis). Reliability and validity for Turkish version of Lei̇cester Cough Questionnaire in copd patients, 2016, Manisa Celal Bayar University.
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from Manisa Celal Bayar University
- Corporate sustainability perceptive and practices: Analyzing the sustainability reports of Turkey's most valuable brands(2023)
- Anomie in university students: MCBU case(2023)
- H. 1326-1329/ M. 1908-1911 tarihli 419 numaralı Manisa Şer'iyye Sicili transkripsiyonu ve değerlendirilmesi(2023)
- Relational examination of eating behaviors, mental stability and physical activity level of adolescents(2023)
- Evaluation of the place of boric acid as a potential therapeutic agent in cervical cancer treatment in the cervical cancer cell line(2023)
- The removal of boron from groundwater using natural zeolite(2024)
